Aurora Cannabis Inc. (ACB)
NASDAQ: ACB · Real-Time Price · USD
4.070
-0.030 (-0.73%)
Oct 16, 2026, 10:05 AM EDT - Market open
Aurora Cannabis Revenue
Aurora Cannabis had revenue of 67.55M CAD in the quarter ending June 30, 2026, a decrease of -8.80%. This brings the company's revenue in the last twelve months to 314.07M, up 12.35% year-over-year. In the fiscal year ending March 31, 2026, Aurora Cannabis had annual revenue of 320.59M with 10.97% growth.
Revenue (ttm)
314.07M CAD
Revenue Growth
+12.35%
P/S Ratio
1.22
Revenue / Employee
305,517 CAD
Employees
1,028
Market Cap
267.08M USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 320.59M | 31.68M | 10.97% |
| Mar 31, 2025 | 288.91M | 19.27M | 7.15% |
| Mar 31, 2024 | 269.64M | 45.83M | 20.48% |
| Mar 31, 2023 | 223.80M | 2.47M | 1.11% |
| Jun 30, 2022 | 221.34M | -23.91M | -9.75% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Emergent BioSolutions | 770.20M |
| Akebia Therapeutics | 219.06M |
| Canopy Growth | 206.77M |
| Kamada | 191.85M |
| Glass House Brands | 176.98M |
| Lifecore Biomedical | 129.46M |
| Anika Therapeutics | 120.65M |
| ADC Therapeutics | 79.58M |
ACB News
- 1 day ago - Aurora Cannabis (ACB) Board Urges Shareholders to Reject Curaleaf's Acquisition Proposal - GuruFocus
- 1 day ago - Aurora Cannabis (ACB) Explores Strategic Alternatives Amid Hostile Curaleaf Offer - GuruFocus
- 1 day ago - Aurora entered confidentiality agreements with multiple parties amid review - TheFly
- 1 day ago - Aurora Cannabis reconfirms recommendation to reject Curaleaf offer - TheFly
- 1 day ago - Aurora Cannabis Reaffirms Recommendation to Shareholders: REJECT Curaleaf's Revised Hostile Bid; Preserve Opportunities for Future Upside - PRNewsWire
- 3 days ago - Aurora Cannabis Stock Has Soared 25% Since Curaleaf First Made an Offer to Buy Its Business. Here's Why I Think It Can Go Even Higher - The Motley Fool
- 8 days ago - Aurora Cannabis (ACB) Completes Expansion of German Production Facility - GuruFocus
- 8 days ago - Aurora Cannabis completes expansion of European EU-GMP manufacturing facility - TheFly